Paris, France - January 29th, 2024 - Mérieux Equity Partners (“MxEP”) is delighted to announce the acquisition of a majority stake in InnoSyn (“the Company”) through its Buyout fund, Mérieux Participations 4 (“MP4”). This strategic investment aims to support InnoSyn in catalyzing a new phase...

As a society, we are currently facing two major challenges: the safeguarding of our future energy supply by the transfer from fossil fuels to sustainable energy sources, and, the reduction of emission of the greenhouse gas CO2....

Our Hydratase Technology is the next generation of idea development available in our expanding portfolio. Partner with us in our successful track record of development and implementation of new and improved processes to chemicals for all market segments. Watch the video: Your browser does not...

Marijn Rijkers, Program Director Biobased shared and discussed his vision towards transition to circular chemicals and materials; What it takes to make it happen. Read the full article...

Dutch television program “Nederland Maakt Het” recorded InnoSyn in action. Have a look!...

Sodium azide is the reagent of choice to prepare sterically hindered amines, triazoles and tetrazoles, functional moieties often encountered in new APIs (Active Pharmaceutical Ingredients). However, the use of azides in batch-wise productions is severely hampered by safety risks. Sodium azide is highly toxic, can...